Friday, February 07, 2020 1:04:49 PM
Dr. Abate is a leader in pharma and diagnostics industries. He currently practices as a consultant in Medical Affairs, Clinical Development, and Pharmacovigilance with Vite-Scientia Consulting. He has experience in instituting the processes and controls needed to protect financial integrity and manage risks, yielding impressive results in both top-line and bottom-line efficiencies. He is an expert developer of high-performance cultures with a demonstrable capacity in navigating positive change management while addressing mission-critical business needs. He holds expertise in selecting, training and developing top-performing executive talent across multifaceted capacities with verifiable success in the architecture and management of globally-scaled businesses.
Recent UEEC News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 10:05:42 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 09:10:10 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM